Daniel M. Scolnick, partner and registered patent attorney at Pepper Hamilton, will be speaking at The Business of Regenerative Medicine: Innovation, Clinical Translation & Entrepreneurship event hosted by the University of Pennsylvania Perelman School of Medicine. Mr. Scolnick will be presenting “Who Owns CRISPR?: The Patent Fight Over the Next Big Thing” on Wednesday, July 18 at 1:35 PM on Session XII: Intellectual Property and Licensing: Turning Science Into Business Into Public Benefit.
Pepper Hamilton is a sponsor.
University of Pennsylvania - Smilow Center for Translational Research
3400 Civic Center Boulevard
Philadelphia, PA 19104